title: Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.
abstract: Inherited factor X deficiency (FXD) is a rare (1:1,000,000) recessive bleeding disorder. The clinical and laboratory phenotypes of FXD are poorly correlated and few regional studies on the genotype and the clinical manifestations of FXD are known. To understand the association between clinical manifestations and causative genotype, detailed evaluation of bleeding pattern in a high number of patients is needed. This international study analysed the phenotype and genotype of 102 subjects from Central Europe (Germany, Poland and Slovakia) and Latin America (Costa Rica and Venezuela) with causative mutations in the F10 gene, via sequencing. Twenty-eight homozygous, seven compound-heterozygous and 67 heterozygous FXD subjects were characterized. Twenty-nine different causative mutations, including 15 novel mutations, were analysed. Spontaneous bleeding symptoms in 42 symptomatic individuals (26 homozygous, seven compound heterozygous and nine heterozygous) comprised easy bruising (55%), haematoma (43%), epistaxis (36%), haemarthrosis (33%), intracranial haemorrhage (ICH; 21%), and gastrointestinal (GI) haemorrhage (12%). The manifestation of bleeding symptoms in 9 of 67 (13%) symptomatic heterozygous subjects is described. The bleeding patterns of the enrolled patients showed differences that are associated with the types of F10 mutation, and the corresponding genotypes. The homozygous patients were evaluated for genotype-phenotype correlation. The results suggested that ICH seems to be associated with the F10 mutation Gly380Arg, and possibly with the mutations IVS7-1G>A and Tyr163delAT. A tentative association of other mutations to severe symptoms such as haemarthrosis and GI haemorrhage is reported. The severity of FXD, the genotype-phenotype association, and the results of regional studies are discussed.
authors.affiliation: Institute of Human Genetics, University of Greifswald, Greifswald, and Hess Children's Hospital, Klinikum Bremen-Mitte, Bremen, Germany. herrmafh@uni-greifswald.de
authors.forename: F H
authors.initials: FH
authors.lastname: Herrmann
authors.forename: G
authors.initials: G
authors.lastname: Auerswald
authors.forename: A
authors.initials: A
authors.lastname: Ruiz-Saez
authors.forename: M
authors.initials: M
authors.lastname: Navarrete
authors.forename: H
authors.initials: H
authors.lastname: Pollmann
authors.forename: S
authors.initials: S
authors.lastname: Lopaciuk
authors.forename: A
authors.initials: A
authors.lastname: Batorova
authors.forename: K
authors.initials: K
authors.lastname: Wulff
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003364:Costa Rica / Q000453:epidemiology; D004844:Epistaxis / Q000453:epidemiology / Q000235:genetics; D005060:Europe / Q000453:epidemiology; D005170:Factor X / Q000235:genetics; D005171:Factor X Deficiency / Q000151:congenital / Q000453:epidemiology / Q000235:genetics*; D005260:Female; D006395:Hemarthrosis / Q000453:epidemiology / Q000235:genetics; D006406:Hematoma / Q000453:epidemiology / Q000235:genetics; D006470:Hemorrhage / Q000453:epidemiology / Q000235:genetics; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D015995:Prevalence; D014687:Venezuela / Q000453:epidemiology
chemical_list: D005170:Factor X